Which route is commonly used for administering Dopamine?

Which route is commonly used for administering Dopamine?

• A. IM Injection
• B. Subcutaneous Injection
• C. IV/IO Infusion
• D. Oral

Answer: (C)

Dopamine is primarily administered via intravenous (IV) or intraosseous (IO) infusion due to its pharmacokinetic properties. This method allows for rapid delivery of the drug directly into the bloodstream, providing an immediate effect, which is critical in emergency situations where dopamine is used to optimize cardiac output and blood pressure. The IV/IO route ensures that the drug can reach systemic circulation quickly, making it especially valuable in acute care settings. Other routes, such as intramuscular (IM) and subcutaneous injections, are not ideal for administering dopamine. These routes would result in delayed absorption and a slower onset of action, which may not be sufficient for conditions requiring immediate hemodynamic support. Additionally, oral administration of dopamine is ineffective as it undergoes significant first-pass metabolism in the liver, which reduces its bioavailability. Therefore, the IV/IO infusion route is the preferred choice for achieving the desired therapeutic effects of dopamine in a clinical setting.

Dopamine is primarily administered via intravenous (IV) or intraosseous (IO) infusion due to its pharmacokinetic properties. This method allows for rapid delivery of the drug directly into the bloodstream, providing an immediate effect, which is critical in emergency situations where dopamine is used to optimize cardiac output and blood pressure. The IV/IO route ensures that the drug can reach systemic circulation quickly, making it especially valuable in acute care settings.

Other routes, such as intramuscular (IM) and subcutaneous injections, are not ideal for administering dopamine. These routes would result in delayed absorption and a slower onset of action, which may not be sufficient for conditions requiring immediate hemodynamic support. Additionally, oral administration of dopamine is ineffective as it undergoes significant first-pass metabolism in the liver, which reduces its bioavailability. Therefore, the IV/IO infusion route is the preferred choice for achieving the desired therapeutic effects of dopamine in a clinical setting.